A Phase 1 Single and Multiple Ascending Dose (SAD/MAD) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AV-101, a Novel Inhaled Dry Powder Formulation of Imatinib in Healthy Subjects
暂无分享,去创建一个
M. Chakinala | M. Kankam | H. Gillies | J. Feldman | V. Mclaughlin | R. Niven | N. Hill | M. Humbert | M. Hoeper | B. Dake